Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 49 EP1221 | DOI: 10.1530/endoabs.49.EP1221

1‘C.I.Parhon’ National Institute of Endocrinology, Bucharest, Romania; 2‘Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania.


Introduction: Differentiated thyroid carcinoma is a rare entity in pediatric population, with particularities in diagnosis, management and outcomes.

Methods, aim: Retrospective noninterventional study describing clinical presentation and outcomes of children with DTC.

Results: Between 2011 and 2017 54 children and adolescents aged 7.8–18 years (mean age at diagnoses 14.4 years) with DTC were diagnosed/followed up in our Institution. The female to male ratio was 3.5:1. In 70% cases unilateral thyroid nodule was the first manifestation of the disease, in 25.9% cases the DTC was diagnosed during the follow-up for chronic thyroid pathology, whereas in 3.7% cases cervical lymph node enlargement was the first clinical sign. 29.6% patients had cervical node involvement at diagnosis, 9.3% had pulmonary metastases. The initial tumour size (over 4 cm diameter), the diffuse sclerosing form of papillary cancer were independent risk factors for initial metastasis. A total thyroidectomy was performed in 58.5% cases, a total thyroidectomy with central neck dissection in 41.5% cases. 57.4% patients were classifies as low risk, 18.6% as high risk patients. The follow-up period was between 1 and 98 month, with an average of 30.4 months. At the last visit 36.3% patients had a good response to therapy, 28.5% were in complete remission of the disease and 9.5% had stable persistent disease.

Conclusion: DTC in children and adolescents has good prognosis even in loco-regionaly advanced forms of the disease.

Volume 49

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.